Brain Structural Effects of Antidepressant Treatment in Major Depression

Author(s): Nicola Dusi, Stefano Barlati, Antonio Vita, Paolo Brambilla

Journal Name: Current Neuropharmacology

Volume 13 , Issue 4 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Depressive disorder is a very frequent and heterogeneous syndrome. Structural imaging techniques offer a useful tool in the comprehension of neurobiological alterations that concern depressive disorder. Altered brain structures in depressive disorder have been particularly located in the prefrontal cortex (medial prefrontal cortex and orbitofrontal cortex, OFC) and medial temporal cortex areas (hippocampus). These brain areas belong to a structural and functional network related to cognitive and emotional processes putatively implicated in depressive symptoms. These volumetric alterations may also represent biological predictors of response to pharmacological treatment. In this context, major findings of magnetic resonance (MR) imaging, in relation to treatment response in depressive disorder, will here be presented and discussed.

Keywords: amitriptyline, amygdala, cingulate, citalopram, doxepine, fluoxetine, fluxovamine, hippocampus, mirtazapine, paroxetine, prefrontal cortex, reboxetine, sertraline, trimipramine, venlafaxine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [458 - 465]
Pages: 8
DOI: 10.2174/1570159X1304150831121909
Price: $65

Article Metrics

PDF: 34